M13.0
Polyarthritis, unspecified
Polyarthritis, unspecified (M13.0) is a clinical classification representing the inflammation of five or more joints simultaneously when the specific underlying etiology or type of arthritis (such as rheumatoid arthritis, psoriatic arthritis, or crystalline arthropathy) has not been identified or documented. This condition describes a syndrome rather than a definitive disease entity and is often utilized during the initial diagnostic phase or when diagnostic criteria for more specific autoimmune conditions are not yet fully met. The inflammatory process typically involves synovial thickening and joint effusion, which can lead to progressive joint damage if the primary cause is not managed. Differential diagnosis is extensive, requiring the clinician to distinguish between autoimmune, viral, metabolic, and reactive triggers.
Clinical Symptoms
- Joint pain affecting five or more joints (polyarticular)
- Significant joint swelling (synovitis)
- Morning stiffness lasting more than 30 to 60 minutes
- Warmth and redness over the affected joints
- Restricted range of motion in multiple joints
- Systemic fatigue and malaise
- Generalized joint tenderness on palpation
- Low-grade fever
- Difficulty with activities of daily living due to joint dysfunction
- Symmetrical or asymmetrical joint involvement
Common Causes
- Early-stage rheumatoid arthritis (prior to meeting full ACR/EULAR criteria)
- Systemic lupus erythematosus (SLE)
- Viral infections (e.g., Parvovirus B19, Hepatitis B or C, Rubella, HIV)
- Reactive arthritis following gastrointestinal or urogenital infections
- Polyarticular gout or pseudogout (calcium pyrophosphate deposition)
- Psoriatic arthritis (in the absence of obvious skin lesions)
- Sarcoidosis
- Connective tissue diseases (e.g., Sjögren's syndrome, systemic sclerosis)
- Environmental triggers in genetically predisposed individuals
- Paraneoplastic syndromes
Documentation & Coding Tips
Document the exact count and anatomical distribution of affected joints to justify the use of a polyarthritis code over monoarthritis or oligoarthritis.
Example: Patient presents with persistent pain and swelling in 6 joints including bilateral metacarpophalangeal joints, bilateral wrists, and both knees. Symptoms have persisted for 10 weeks. This chronic condition limits the patient's ability to perform activities of daily living such as dressing and cooking. Billing Focus: Specificity of joint count (5 or more) and duration. Risk Adjustment: Chronic status and functional impairment documentation.
Billing Focus: Documentation of 5 or more joints involved to meet the clinical definition of polyarthritis.
Describe the presence or absence of symmetry in joint involvement as this is a key differentiator for underlying systemic conditions like rheumatoid arthritis.
Example: Evaluation reveals symmetrical swelling and tenderness of the bilateral proximal interphalangeal joints and wrists. Morning stiffness lasts approximately 90 minutes. These findings are highly suggestive of an inflammatory process. Billing Focus: Laterality and symmetry of joint involvement. Risk Adjustment: Symmetry is a clinical marker for more severe systemic inflammatory disorders.
Billing Focus: Laterality and anatomical site documentation for all involved joints.
Clearly state if the polyarthritis is primary or secondary to another systemic disease, even if that disease is currently being investigated.
Example: The patient exhibits polyarthritis involving the small joints of the hands and feet, suspected to be secondary to systemic lupus erythematosus (SLE) given the concurrent malar rash and photosensitivity. Laboratory tests for ANA and dsDNA are pending. Billing Focus: Connection between arthritic manifestations and systemic etiologies. Risk Adjustment: Linking symptoms to a systemic condition increases the risk score profile.
Billing Focus: Causality or association with underlying systemic conditions.
Include objective findings from physical examinations such as effusion, range of motion limitations, and warmth to support the medical necessity of treatment.
Example: Physical exam of the right and left ankles and midfoot shows palpable effusions, increased local temperature, and a 50 percent reduction in passive range of motion due to pain. Patient currently taking prednisone 10mg daily for symptom control. Billing Focus: Objective clinical evidence of inflammation. Risk Adjustment: Documentation of medication management for chronic inflammation.
Billing Focus: Objective findings supporting the level of medical decision making (MDM) for E/M coding.
Specify whether the condition is acute, subacute, or chronic to facilitate accurate ICD-10-CM selection and clinical timeline tracking.
Example: Diagnosis is chronic polyarthritis, unspecified, as the patient has experienced continuous multi-joint inflammation for over 6 months without a definitive serological diagnosis. Condition is stable on current NSAID regimen. Billing Focus: Temporal specificity (acute vs chronic). Risk Adjustment: Chronic conditions are tracked for longitudinal risk assessment.
Billing Focus: Use of temporal qualifiers to define the episode of care.
Relevant CPT Codes
-
99214 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a moderate level of medical decision making
Polyarthritis involves multiple joints and often complex diagnostic reasoning, typically meeting moderate MDM requirements.
-
99213 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a low level of medical decision making
Appropriate for routine follow-ups of stable polyarthritis where diagnostic complexity is low.
-
20610 - Arthrocentesis, aspiration and/or injection, major joint or bursa; without ultrasound guidance
Diagnostic aspiration is crucial in polyarthritis to rule out crystalline disease or infection.
-
86038 - Antinuclear antibodies (ANA), RIA, EIA or IFA
Standard screening for connective tissue diseases that manifest as polyarthritis.
-
86200 - Cyclic citrullinated peptide (CCP) antibody, quantitative
High specificity for identifying Rheumatoid Arthritis in patients with polyarthritis symptoms.
-
77075 - Radiologic examination, bone survey; complete
Used to assess the extent of joint damage across multiple sites in polyarthritis.
-
99204 - Office or other outpatient visit for the evaluation and management of a new patient, which requires a moderate level of medical decision making
The initial evaluation of polyarthritis is highly complex, requiring a thorough history and review of systems.
-
86430 - Rheumatoid factor; qualitative
Fundamental test in the differential diagnosis of inflammatory polyarthritis.
-
85652 - Sedimentation rate, erythrocyte; automated
Used to monitor the inflammatory activity of polyarthritis.
-
97110 - Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility
Rehabilitation is a key component of polyarthritis management to prevent contractures.
Related Diagnoses
- M06.9 - Rheumatoid arthritis, unspecified
- M15.0 - Primary generalized (osteo)arthrosis
- M35.9 - Systemic involvement of connective tissue, unspecified
- M13.111 - Monoarthritis, not elsewhere classified, right shoulder
- M12.9 - Arthropathy, unspecified
- R73.09 - Other abnormal glucose
- M08.00 - Unspecified juvenile rheumatoid arthritis, unspecified site
- M10.9 - Gout, unspecified
- M32.9 - Systemic lupus erythematosus, unspecified
- M25.50 - Pain in unspecified joint